Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness

被引：208

作者：

Luks, Andrew M. ^{[1
]}

McIntosh, Scott E. ^{[2
]}

Grissom, Colin K. ^{[3
]}

Auerbach, Paul S. ^{[4
]}

Rodway, George W. ^{[5
,6
]}

Schoene, Robert B. ^{[7
]}

Zafren, Ken ^{[4
,8
]}

Hackett, Peter H. ^{[9
,10
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA

[2] Univ Utah, Div Emergency Med, Salt Lake City, UT USA

[3] Univ Utah, Intermt Med Ctr, Div Pulm & Crit Care Med, Salt Lake City, UT USA

[4] Stanford Univ, Sch Med, Div Emergency Med, Dept Surg, Palo Alto, CA 94304 USA

[5] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA

[6] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA

[7] Bozeman Deaconess Hosp, Bozeman, MT USA

[8] Himalayan Rescue Assoc, Kathmandu, Nepal

[9] Univ Colorado Denver, Sch Med, Altitude Res Ctr, Div Emergency Med, Denver, CO USA

[10] Inst Altitude Med, Telluride, CO USA

来源：

WILDERNESS & ENVIRONMENTAL MEDICINE | 2010年 / 21卷 / 02期

关键词：

high altitude; acute mountain sickness; high altitude pulmonary edema; high altitude cerebral edema; acetazolamide; dexamethasone; nifedipine; salmeterol; tadalafil; sildenafil; ACUTE MOUNTAIN-SICKNESS; PULMONARY-EDEMA; GINKGO-BILOBA; RANDOMIZED-TRIAL; SIMULATED DESCENT; CEREBRAL EDEMA; ACETAZOLAMIDE; DEXAMETHASONE; PROPHYLAXIS; NIFEDIPINE;

D O I：

10.1016/j.wem.2010.03.002

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

To provide guidance to clinicians about best practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for the prevention and treatment of acute mountain sickness (AMS), high altitude cerebral edema (HACE), and high altitude pulmonary edema (HAPE). These guidelines present the main prophylactic and therapeutic modalities for each disorder and provide recommendations for their roles in disease management. Recommendations are graded based on the quality of supporting evidence and balance between the benefits and risks/burdens according to criteria put forth by the American College of Chest Physicians. The guidelines also provide suggested approaches to the prevention and management of each disorder that incorporate these recommendations.

引用

页码：146 / 155

页数：10

共 45 条

[1] Physiological aspects of high-altitude pulmonary edema [J].

Bärtsch, P ;

Mairbäurl, H ;

Maggiorini, M ;

Swenson, ER .

JOURNAL OF APPLIED PHYSIOLOGY, 2005, 98 (03) :1101-1110

[2]

Bärtsch P, 2002, LANCET, V360, P571, DOI 10.1016/S0140-6736(02)09723-4

[3] PREVENTION OF HIGH-ALTITUDE PULMONARY-EDEMA BY NIFEDIPINE [J].

BARTSCH, P ;

MAGGIORINI, M ;

RITTER, M ;

NOTI, C ;

VOCK, P ;

OELZ, O .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (18) :1284-1289

[4] TREATMENT OF ACUTE MOUNTAIN-SICKNESS BY SIMULATED DESCENT - A RANDOMIZED CONTROLLED TRIAL [J].

BARTSCH, P ;

MERKI, B ;

HOFSTETTER, D ;

MAGGIORINI, M ;

KAYSER, B ;

OELZ, O .

BRITISH MEDICAL JOURNAL, 1993, 306 (6885) :1098-1101

[5] Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: The prophylactic acetazolamide dosage comparison for efficacy (PACE) trial [J].

Basnyat, B ;

Gertsch, JH ;

Holck, PS ;

Johnson, EW ;

Luks, AM ;

Donham, BP ;

Fleischman, RJ ;

Gowder, DW ;

Hawksworth, JS ;

Jensen, BT ;

Kleiman, RJ ;

Loveridge, AH ;

Lundeen, EB ;

Newman, SL ;

Noboa, JA ;

Miegs, DP ;

O'Beirne, KA ;

Philpot, KB ;

Schultz, MN ;

Valente, MC ;

Wiebers, MR ;

Swenson, ER .

HIGH ALTITUDE MEDICINE & BIOLOGY, 2006, 7 (01) :17-27

[6] Acetazolamide fails to decrease pulmonary artery pressure at high altitude in partially acclimatized humans [J].

Basnyat, Buddha ;

Hargrove, Jenny ;

Holck, Peter S. ;

Srivastav, Soni ;

Alekh, Kshitiz ;

Ghimire, Laxmi V. ;

Pandey, Kaushal ;

Griffiths, Anna ;

Shankar, Ravi ;

Kaul, Komal ;

Paudyal, Asmita ;

Stasiuk, David ;

Basnyat, Rose ;

Davis, Christopher ;

Southard, Andrew ;

Robinson, Cathleen ;

Shandley, Thomas ;

Johnson, Dan W. ;

Zafren, Ken ;

Williams, Sarah ;

Weiss, Eric A. ;

Farrar, Jeremy J. ;

Swenson, Erik R. .

HIGH ALTITUDE MEDICINE & BIOLOGY, 2008, 9 (03) :209-216

[7] Effect of Six Days of Staging on Physiologic Adjustments and Acute Mountain Sickness during Ascent to 4300 Meters [J].

Beidleman, Beth A. ;

Fulco, Charles S. ;

Muza, Stephen R. ;

Rock, Paul B. ;

Staab, Janet E. ;

Forte, Vincent A. ;

Brothers, Michael D. ;

Cymerman, Allen .

HIGH ALTITUDE MEDICINE & BIOLOGY, 2009, 10 (03) :253-260

[8] Effect of Ascent Protocol on Acute Mountain Sickness and Success at Muztagh Ata, 7546 m [J].

Bloch, Konrad E. ;

Turk, Alexander J. ;

Maggiorini, Marco ;

Hess, Thomas ;

Merz, Tobias ;

Bosch, Martina M. ;

Barthelmes, Daniel ;

Hefti, Urs ;

Pichler, Jacqueline ;

Senn, Oliver ;

Schoch, Otto D. .

HIGH ALTITUDE MEDICINE & BIOLOGY, 2009, 10 (01) :25-32

[9] Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness -: A randomized, placebo-controlled trial [J].

Chow, T ;

Browne, V ;

Heileson, HL ;

Wallace, D ;

Anholm, J .

ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (03) :296-301

[10] A RANDOMIZED TRIAL OF DEXAMETHASONE AND ACETAZOLAMIDE FOR ACUTE MOUNTAIN-SICKNESS PROPHYLAXIS [J].

ELLSWORTH, AJ ;

LARSON, EB ;

STRICKLAND, D .

AMERICAN JOURNAL OF MEDICINE, 1987, 83 (06) :1024-1030

← 1 2 3 4 5 →